Survival in good risk chronic phase patients with chronic myelogenous leukemia. Shown are results for patients under 20 years of age (n = 49), between 20 and 35 years old (n = 108), and older than 35 (n = 137); with HLA-matched unrelated donors; bone marrow transplant less than 12 months from diagnosis.